{"id":"https://openalex.org/W2128667375","doi":null,"title":"Can gallium-68 compounds partly replace (18)F-FDG in PET molecular imaging?","display_name":"Can gallium-68 compounds partly replace (18)F-FDG in PET molecular imaging?","publication_year":2009,"publication_date":"2009-05-01","ids":{"openalex":"https://openalex.org/W2128667375","mag":"2128667375","pmid":"https://pubmed.ncbi.nlm.nih.gov/19675859"},"language":"en","primary_location":{"id":"pmid:19675859","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19675859","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hellenic journal of nuclear medicine","raw_type":"Editorial"},"volume":null,"type":"editorial","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083699739","display_name":"Margarita Pagou","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Margarita Pagou","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031935072","display_name":"Imene Zerizer","orcid":"https://orcid.org/0009-0002-3297-9324","observed_orcids":["https://orcid.org/0009-0002-3297-9324"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Imene Zerizer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5000411947","display_name":"ADIL M. AL-NAHHAS","orcid":"https://orcid.org/0000-0002-2887-8187","observed_orcids":["https://orcid.org/0000-0002-2887-8187"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Adil Al-Nahhas","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":20,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"12","issue":"2","first_page":"102","last_page":"5"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9535999894142151,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9535999894142151,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10754","display_name":"Neuroendocrine Tumor Research Advances","score":0.02280000038444996,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10522","display_name":"Medical Imaging Techniques and Applications","score":0.018799999728798866,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gallium-68","display_name":"gallium-68","score":0.9810000061988831},{"id":"https://openalex.org/keywords/neuroendocrine-tumors","display_name":"neuroendocrine tumors","score":0.8370000123977661},{"id":"https://openalex.org/keywords/pheochromocytoma","display_name":"pheochromocytoma","score":0.8650000095367432},{"id":"https://openalex.org/keywords/paraganglioma","display_name":"paraganglioma","score":0.996999979019165},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.7639999985694885},{"id":"https://openalex.org/keywords/bombesin-receptor","display_name":"bombesin receptor","score":0.8240000009536743},{"id":"https://openalex.org/keywords/tumor-hypoxia","display_name":"tumor hypoxia","score":0.859000027179718},{"id":"https://openalex.org/keywords/inflammation-imaging","display_name":"inflammation imaging","score":0.6470000147819519},{"id":"https://openalex.org/keywords/radionuclide-therapy","display_name":"radionuclide therapy","score":0.8569999933242798}],"concepts":[{"id":"https://openalex.org/C2779931791","wikidata":"https://www.wikidata.org/wiki/Q161515","display_name":"DOTA","level":3,"score":0.7518858909606934},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7315961718559265},{"id":"https://openalex.org/C2776734335","wikidata":"https://www.wikidata.org/wiki/Q581592","display_name":"Paraganglioma","level":2,"score":0.5006756782531738},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.48421740531921387},{"id":"https://openalex.org/C136339569","wikidata":"https://www.wikidata.org/wiki/Q1142297","display_name":"Molecular imaging","level":3,"score":0.46601417660713196},{"id":"https://openalex.org/C2993559085","wikidata":"https://www.wikidata.org/wiki/Q2126444","display_name":"Radionuclide therapy","level":2,"score":0.42275458574295044},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.38291025161743164},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.362776517868042},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.3039841651916504},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.09945797920227051},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D005710","descriptor_name":"Gallium Radioisotopes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D007089","descriptor_name":"Image Enhancement","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D009683","descriptor_name":"Nuclear Medicine","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":true},{"descriptor_ui":"D015336","descriptor_name":"Molecular Probe Techniques","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":true},{"descriptor_ui":"D019275","descriptor_name":"Radiopharmaceuticals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019788","descriptor_name":"Fluorodeoxyglucose F18","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D049268","descriptor_name":"Positron-Emission Tomography","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:19675859","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19675859","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hellenic journal of nuclear medicine","raw_type":"Editorial"},{"id":"mag:2128667375","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19675859","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":14,"referenced_works":["https://openalex.org/W230503234","https://openalex.org/W1893174029","https://openalex.org/W1976319698","https://openalex.org/W1986723218","https://openalex.org/W2001813000","https://openalex.org/W2016018253","https://openalex.org/W2026893437","https://openalex.org/W2028355418","https://openalex.org/W2072193074","https://openalex.org/W2107303896","https://openalex.org/W2122592409","https://openalex.org/W2164873116","https://openalex.org/W2181785071","https://openalex.org/W2185007975"],"related_works":["https://openalex.org/W1976616768","https://openalex.org/W2060765265","https://openalex.org/W7099331038","https://openalex.org/W58802875","https://openalex.org/W2167800847","https://openalex.org/W2161377113","https://openalex.org/W2338587759","https://openalex.org/W2112295833","https://openalex.org/W2003291711","https://openalex.org/W2025387700"],"abstract_inverted_index":{"The":[0,38,69],"development":[1],"of":[2,15,21,33,40,108,124,145,167,183,198,202],"gallium-68":[3],"-1,4,7,10-tetraazacyclodecane-1,4,7,10-tetraacetic":[4],"acid":[5],"((68)Ga-DOTA)":[6],"compounds":[7],"was":[8],"made":[9,185],"possible":[10],"due":[11],"to":[12,55,67,139,171,195],"the":[13,19,25,31,106,122,165,172,180,196],"chemistry":[14],"(68)Ga,":[16],"which":[17],"matches":[18],"pharmacokinetics":[20],"many":[22],"peptides,":[23],"specially":[24],"chelators":[26],"DOTA":[27,142],"and":[28,89,93,114,129,207],"DOTAderivatives":[29],"with":[30,47,64,73,102],"formation":[32],"stable":[34],"(68)Ga":[35],"(3+)":[36],"complexes.":[37],"availability":[39],"this":[41],"tracer":[42],"from":[43],"a":[44,48,161,188,199],"germanium-68-gallium-68":[45],"generator":[46],"relatively":[49],"long":[50],"half-life":[51],"makes":[52],"it":[53],"attractive":[54],"use":[56,107,166],"in":[57,105,117],"busy":[58],"nuclear":[59],"medicine":[60],"departments,":[61],"particularly":[62,79],"those":[63],"limited":[65],"access":[66],"cyclotrons.":[68],"recent":[70,181],"clinical":[71,100,203],"experience":[72],"(68)Ga-peptides":[74],"includes":[75],"imaging":[76,123,134,154],"neuroendocrine":[77],"tumours":[78,85,128,206],"carcinoid,":[80],"as":[81,83,87],"well":[82],"neuroectodermal":[84],"such":[86],"phaeochromocytoma":[88],"paraganglioma.":[90],"In":[91,137,178],"vitro":[92],"animal":[94],"testing":[95],"are":[96],"still":[97],"progressing":[98],"alongside":[99],"studies,":[101],"promising":[103],"results":[104],"(68)Ga-DOTA-rhenium-cyclized":[109],"alpha-melanocyte":[110],"stimulating":[111],"hormone":[112],"(MSH)":[113],"(68)Ga-DOTA-napamide":[115],"(NAP)":[116],"melanoma,":[118],"(68)Ga-DOTA-PEG(4)-BN(7-14)":[119],"(PESIN)":[120],"for":[121,133,153,175],"bombesin":[125],"receptor-":[126],"positive":[127,162],"(68)Ga-ethylene":[130],"dicysteine-metronidazole":[131],"(EC-MN)":[132],"tumour":[135],"hypoxia.":[136],"addition":[138],"tumours,":[140],"(68)Ga-":[141],"peptide":[143,147],"inhibitor":[144],"vascular":[146],"protein":[148],"1(VAP-P1)":[149],"is":[150,164],"being":[151],"assessed":[152],"inflammatory":[155],"reaction.":[156],"An":[157],"additional":[158],"value":[159],"following":[160],"scan":[163],"beta":[168],"emitters":[169],"labelled":[170],"same":[173],"peptides":[174],"radionuclide":[176],"treatment.":[177],"conclusion,":[179],"introduction":[182],"(68)Ga-peptides,":[184],"available":[186],"by":[187],"convenient":[189],"(68)Ga/(68)Ge":[190],"generator,":[191],"could":[192],"greatly":[193],"contribute":[194],"management":[197],"wide":[200],"range":[201],"conditions":[204],"including":[205],"inflammation.":[208]},"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}